Clinical Research Directory
Browse clinical research sites, groups, and studies.
DOvEE - Diagnosing Ovarian & Endometrial Cancer Early
Sponsor: McGill University
Summary
This study hopes to improve early detection of ovarian and endometrial cancers. It will determine if women with bloating, abdominal distension, abdominal/pelvic pain, increased urinary frequency and/or early satiety, benefit from earlier surgery after screening by CA-125 ovarian cancer biomarker and transvaginal ultrasound.
Official title: Diagnosing Ovarian & Endometrial Cancer Early (DOvEE) by Targeting Symptomatic Women
Key Details
Gender
FEMALE
Age Range
45 Years - Any
Study Type
OBSERVATIONAL
Enrollment
13600
Start Date
2012-01
Completion Date
2026-01
Last Updated
2024-05-02
Healthy Volunteers
No
Conditions
Interventions
Blood test: CA-125 biomarker
* CA-125 biomarker blood test at visit 1, day 1. * CA-125 biomarker blood test at visit 2, week 6.
Second Test: Transvaginal Ultrasound
-Transvaginal Ultrasound at visit 1, day 1.
Follow-up phone call
Phone call 6 months after last visit to verify continued health.
Locations (8)
West Island Cancer Wellness Centre
Kirkland, Quebec, Canada
Axion 50 plus
Laval, Quebec, Canada
Clinique Familiale Pas-A-Pas
Montreal, Quebec, Canada
Clinique Médicale du Haut-Anjou
Montreal, Quebec, Canada
McGill University Health Centre, Royal Victoria Hospital
Montreal, Quebec, Canada
Queen Elizabeth Health Centre
Montreal, Quebec, Canada
Lachine Hospital
Montreal, Quebec, Canada
Clinique du Dr. L. Quintal
Saint-Lambert, Quebec, Canada